Leadhopping-and beyond

Expert Opinion on Drug Discovery

Volumn 1, Issue 4, 2006, Pages 311-321

  Cramer, Richard D ^a  

^a TRIPOS INC   (United States)

Author keywords

dbtop; leadhopping; molecular similarity; ROCS; scaffold hopping; shape similarity; Surflex; topomer

Indexed keywords

EID: 80051768265     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.1.4.311     Document Type: Review

References (44)

1. CRAMER RD, POSS MA, HERMSMEIER MA, CAULFIELD TJ, KOWALA MC, VALENTINE MT: Prospective identification of biologically active structures by topomer shape similarity searching. J. Med. Chem. (1999) 42:3919-3933. (Pubitemid 29453472)
2. CRAMER RD, JILEK RJ, GUESSREGEN S, CLARK SJ, WENDT B, CLARK RD: Lead-Hopping. Validation of topomer similarity as a superior predictor of similar biological activities. J. Med. Chem. (2004), 47:6777-6791. (Pubitemid 40053766)
3. RUSH TR, GRANT JA, MOSYAK L, NICHOLLS A: A shape-based 3-d scaffold hopping method and its application to a bacterial protein-protein interaction. J. Med. Chem. (2005) 48:1489-1495. (Pubitemid 40364556)
4. MUCHMORE SW, SOUERS AJ, AKRITOPOULOU-ZANZE I: The use of three dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist. Chem. Biol. Drug Disc. (2006) 67:174-176. (Pubitemid 43881377)
5. LOW CMR, BUCK IM, COOKE T, CUSHNIR JR, KALINDJIAN SB, KOTECHA A, SHANKLEY NP, VINTER JG, WRIGHT L: Scaffold hopping with molecular field points: identification of a cholecystokinin-2 receptor pharmacophore and its use in the design of a prototypical series of pyrroleand imidazole-based CCK2 antagonists. J. Med. Chem. (2005), 48:6790-6802. (Pubitemid 41533101)
6. PERKINS E, SUN D, NGUYEN A et al.: Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast. Cancer Res. (2001) 61:4175-4183. (Pubitemid 32720987)
7. CRAMER RD: Topomer CoMFA: A design methodology for rapid lead optimization. J. Med. Chem. (2003) 46:374-389.
8. ANDREWS KM, CRAMER RD: Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries, J. Med. Chem. (2000) 43:1723-1740. (Pubitemid 30305006)
9. CRAMER RD, SOLTANSHAHI F, JILEK R, CAMPBELL B: Generating and searching 10E20 synthetically accessible structures. Abs ACS (2006), 231st mtg: CINF 38.
10. CLEVES AE, JAIN AN: robust ligand-based modeling of the biological targets of known drugs, J. Med. Chem. (2006) 49:2921-2938.
11. JENKINS JL, GLICK M, DAVIES JW: A 3D similarity method for scaffold hopping from known drugs or natural ligands to new chemotypes, J. Med. Chem. (2004) 49:6144-6159. (Pubitemid 39587240)
12. ZHANG Q, MUEGGE I: Scaffold hopping through virtual screening using 2d and 3d similarity descriptors: ranking, voting, and consensus scoring. J. Med. Chem. (2006) 49:1536-1548. (Pubitemid 43376501)
13. GOOD AC, CHO SJ, MASON JS: Descriptors you can count on? normalized and filtered pharmacophore descriptors for virtual screening. J. Comp.-Aided Mol. Des. (2004) 18:523-527.
14. LENGAUER T, LEMMEN C, RAREY M, ZIMMERMAN S: Novel technologies for virtual screening. Drug Discov. Today (2004) 9:27-34. (Pubitemid 38169029)
15. CRAMER RD, REDL G, BERKOFF CE: Substructural Analysis: A Novel Approach to the Problem of Drug Design. J. Med. Chem. (1974) 17:533-535.
16. WILLETT P, WINTERMAN VA: A Comparison of some measures of intermolecular structural similarity. Quant. Struct.-Act. Relat. (1986) 5:18-25.
17. STIEFL N, WATSON IA, BAUMANN K, ZALIANI A: ErG: 2D Pharmacophore Descriptions for Scaffold Hopping. J. Chem. Inf. Model. (2006) 46:208-220. (Pubitemid 43282116)
18. BARKER EJ, BUTTAR D, COSGROVE DA, GARDINER EJ, KITTS P, WILLETT P, GILLET VJ: Scaffold hopping using clique detection applied to reduced graphs. J. Chem. Inf. Model. (2006) 46:503-511.
19. WOLOHAN PRN, AKELLA LB, DORFMAN RJ, NELL PG, MUNDT SM, CLARK RD: Structural unity analysis identifies lead series and facilitates scaffold hopping in combinatorial chemistry. J. Chem. Inf. Model. (2006) 46:1188-1193. (Pubitemid 43999163)
20. BENDER A, MUSSA HY, GILL GS, GLEN RC. Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT-3D). J. Med. Chem. (2004) 47:6569-6583. (Pubitemid 39662752)
21. BROWN RD, MARTIN YC. Use of Structure-activity data to compare structure-based clustering methods and descriptors for use in compound selection. J. Chem. Inf. Comput. Sci. (1996) 36:572-584. (Pubitemid 126539358)
22. SCHNEIDER G, NEIDHART W, GILLER T, SCHMID G: Scaffold-hopping by topological pharmacophore search: a contribution to virtual screening. Angew. Chem. Int. Ed. (1999) 38:2894-2896. (Pubitemid 29479958)
23. NAERUM L, NORSKOV-LAURITSEN L, OLESEN PH: Scaffold hopping and optimization towards libraries of glycogen synthase kinase-3 inhibitors. Biorg. Med. Chem. Lett. (2002) 12:1525-1528. (Pubitemid 34521927)
24. RENNER S, NOESKE T, PARSONS CG, SCHNEIDER P, WEIL T, SCHNEIDER G: New Allosteric modulators of metabotropic glutamate receptor-5 (mglur5) found by ligand-based virtual screening. Chembiochem (2005) 6:620-625. (Pubitemid 40873758)
25. HOLLIDAY JD, SALIM H, WHITTLE M, WILLETT P: Analysis and display of the size dependence of chemical similarity coefficients. J. Chem. Inf. Comput. Sci. (2003) 43:819-828.
26. WARREN GL, ANDREWS CW, CAPELLI AM et al.: A critical assessment of docking programmes and scoring functions. J. Med. Chem. (2006) (In Press).
27. CUMMINGS MD, DESJARLAIS RL, GIBBS AC, MOHAN V, JAEGER EP: Comparison of automated docking programmes as screening tools. J. Med. Chem. (2005) 48:962-976. (Pubitemid 40270442)
28. PHAM TA, JAIN AN: Parameter Estimation for scoring protein-ligand interactions using negative training data. J. Med. Chem. (2006) (In Press).
29. MITEVA MA, LEE WH, MONTES MO, VILLOUTRIX BO: Fast structure-based virtual ligand screening combining FRED, DOCK, and Surflex. J. Med. Chem. (2005), 48:6012-6022. (Pubitemid 41324611)
30. CHEN H, LYNE PD, GIORDANETTO FJ: On evaluating molecular-docking methods for pose prediction and enrichment factors. J. Chem. Inf. Model. (2006):401.
31. EVERS A, HESSLER G, MATTER H, KLABUNDE T: Virtual Screening of biogenic amine-binding g protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. J. Med. Chem. (2005) 48:5448-5465. (Pubitemid 41209243)
32. HAWKINS PCD: A comparison of structure-based and shape-based tools for virtual screening. Abs ACS (2006) 231st mtg: COMP 79.
33. CRAMER RD, JILEK RJ, ANDREWS KM: dbtop: topomer similarity searching of conventional databases. J. Mol. Graph. Modeling (2002) 20:447-462. (Pubitemid 34312060)
34. JAIN AN: Ligand-based structural hypotheses for virtual screening. J. Med. Chem. (2004), 47:947-961. (Pubitemid 38176797)
35. MASEK BB, MERCHANT A, MATTHEW JB: Molecular shape comparison of angiotensin II receptor antagonists. J. Med. Chem. (1993) 36:1230-1238. (Pubitemid 23159297)
36. GRANT JA, PICKUP BT: A Gaussian Description of Molecular Shape. J. Phys. Chem. (1995) 99:3503-3510.
37. CHEESERIGHT T, MACKEY M, ROSE S, VINTER A: Molecular Field extrema as descriptors of biological activity: definition and validation. J. Chem. Inf. Model. (2006) 46:665-676.
38. JAIN AN: Surflex: fully automatic flexible molecular docking using a molecular similarity-based search engine. J. Med. Chem. (2003) 46:499-511. (Pubitemid 36182752)
39. PATTERSON DE, CRAMER RD, FERGUSON AM, CLARK RD, WEINBERGER LE: Neighborhood behavior: a useful concept for validation of molecular diversity descriptors. J. Med. Chem. (1996) 39:3049-60
40. CRAMER RD, CLARK RD, PATTERSON DE, FERGUSON AM: Bioisosterism as a molecular diversity descriptor: steric fields of single topomeric conformers. J. Med. Chem. (1996) 39:3060-3069. (Pubitemid 26260311)
41. JILEK RJ, CRAMER RD: Topomers: A Validated protocol for their self-consistent generation. J. Chem. Inf. Comp. Sci. (2004) 44:1221-1227.
42. CRAMER RD, PATTERSON DE, BUNCE JD: Comparative molecular field analysis (CoMFA): effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. (1988) 110:5959-5967.
43. ZHU LL, HOU TJ, CHEN LR, XU XJ: 3D QSAR analyses of novel tyrosine kinase inhibitors based on pharmacophore alignment, J. Chem. Inf. Comput. Sci. (2001) 41:1032-1040.
44. CRAMER RD, PATTERSON DE, CLARK RD, SOLTANSHAHI F, LAWLESS MS: Virtual libraries: a new approach to decision making in molecular discovery research. J. Chem. Inf. Comp. Sci. (1998) 6:1010-1023. (Pubitemid 128591263)